Dimensioni, segmenti e analisi del mercato della terapia CAR-T entro il 2025-2031
CAR-T Therapy Market Report Analysis
CAR-T Therapy Market
-
CAGR () -
Market Size
XX milioni di dollari USA nel 2024 -
Market Size
XX milioni di dollari entro il 2031

Report Coverage
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Industry landscape and competition analysis & recent developments
- Detailed company profiles
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Key Players
- Novartis International AG
- Kite Pharma, Inc. (Gilead Sciences, Inc.)
- Juno Therapeutics (Celgene Corporation)
- Bluebird Bio, Inc. (Celgene Corporation)
- Sorrento Therapeutics Inc.
- Mustang Bio, Inc
- Aurora Biopharma Inc.
- Legend Biotech (Genscript Biotech Corporation)
- Pfizer, Inc.
Regional Overview

- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation

- CD 19
- BCMA
- HER2
- GD2
- CD 20
- CD22
- CD30
- CD33
- HER1 e altri

- leucemia linfatica acuta
- leucemia linfatica cronica
- linfoma diffuso a grandi cellule B
- linfoma follicolare
- mieloma multiplo
- glioblastoma
- sarcoma
- neuroblastoma
- leucemia mieloide acuta
- cancro al seno
- cancro al pancreas
- carcinoma epatocellulare
- cancro colorettale e altri

- Nord America
- Europa
- Asia-Pacifico
- Sud e Centro America
- Medio Oriente e Africa